In 2003, more than 48,000 babies were born in the United States as a result of assisted reproductive technology (ART) procedures, according to a new report from the Centers for Disease Control and Prevention. This marks an increase from 45,751 babies in 2002.
Obesity may make it more difficult to detect prostate cancer, leading to delayed diagnosis and putting some men at greater risk of death, according to a multicenter study.
In the latest study examining the controversy over prostate cancer screening, researchers have concluded that screening does not appear to reduce men's risk of dying.
Laserscope, San Jose, CA, has announced that the Centers for Medicare & Medicaid Services has published a technical revision to the 2006 Medicare physician few schedule.
Contrary to previous reports, statins do not appear to reduce the incidence of cancer or cancer deaths, according to a meta-analysis of previous studies (JAMA 2006; 295:74-80). The finding held true for a range of cancers, including prostate cancer.
Trimedyne, Inc., Irvine, CA, has received FDA approval to market its VaporMAX Fiber for use with its Holmium lasers to treat BPH.
Louis R. Kavoussi, MD, has been appointed chairman of the newly combined department of urology at North Shore University Hospital in Manhasset, NY, and Long Island Jewish Medical Center in New Hyde Park, NY.
The NMP22 test (BladderChek, Matritech, Newton, MA) significantly increased the detection of recurrent bladder cancer, finding 99% of the malignancies when used with cystoscopy, according to a study published this week in JAMA (2006; 295:299-305).
Men with erectile dysfunction have a 25% higher risk of subsequent cardiovascular events such as heart attack, stroke, and angina, according to a study published recently in JAMA (2005; 294:2996-3002).
United Healthcare Insurance Co., and sister companies United Healthcare of Georgia Inc., and Golden Rule Insurance Co., have been fined $2.8 million for delaying payment on 75,000 to 80,000 health claims.
Leo Fung, MD, chief of pediatric urology at the University of Minnesota's Medical School, died of cancer on Dec. 10 at the age of 42
A compound found in many fruits and vegetables shows major promise in combating prostate cancer, according to researchers at the University of Wisconsin School of Medicine and Public Health, Madison.
Over the next 2 years, the U.S. Department of Health and Human Services will undertake two key initiatives to expand Medicare beneficiary access to services provided by ambulatory surgery centers, the American Association of Ambulatory Surgery Centers reported.
The FDA has approved sorafenib (Nexavar) for the treatment of advanced renal cell carcinoma.
Paris--Adding a form of high-dose calcitriol to docetaxel (Taxotere) offers improved survival over docetaxel alone in men with metastatic androgen-independent prostate cancer, according to results of a multicenter trial presented at the 13th European Cancer Conference (ECCO-13) here. Further, the addition of the calcitriol formulation, known as DN-101, to the chemotherapy agent produced an unanticipated advantage in a reduced number of serious gastrointestinal and thromboembolic adverse events.
Amsterdam, Netherlands--Participants in an AUA-sponsored laparoscopic videotape mentoring course, offered as part of a skills-based learning course, report an increase in their laparoscopic caseload and in the performance of clinical laparoscopic suturing.
If you perform a diagnostic retrograde (52005) and the insertion of a stent (52332) at the same setting, each should be billed separately.
Practicing urologists as a whole must stay close to the cutting edge of laparoscopic renal surgery.
Amherst, NY--Urologist and author J. Stephen Jones, MD, offers patients a thorough orientation to prostate health in The Complete Prostate Book, published by Prometheus Books. Divided into three sections, the 425-page, illustrated volume covers basic prostate anatomy and function, common benign conditions, and prostate cancer, as well as what to expect in a prostate exam, effect of sexual activity on the prostate, common symptoms, tests, and treatment options.
A phase III study examining the use of the phosphodiesterase type-5 inhibitor tadalafil in men with BPH is planned for 2006. The scheduled trial follows results of a double-blind, placebo-controlled phase II study showing clinically meaningful and statistically significant improvement in lower urinary tract symptoms in men with BPH who were treated for 6 weeks with once-daily tadalafil, 5 mg, according to Lilly ICOS LLC.
Whether you're interested in adding an associate to your practice or are seeking a move yourself, you're likely to en-counter physician recruiters. While working with a recruiter is not for every physician, it can save time and allow you to focus on what really matters: patient care.
Peripheral lesions are more amenable to ablation and are technically easier, but endophytic neoplasms can be performed with precise intraoperative imaging.
Amsterdam, Netherlands--Three-dimensional computed tomography reconstruction of the pelvicalyceal system helps in the planning and execution of percutaneous nephrolithotomy, but the relative value of each reconstruction method is not known.
Amsterdam, Netherlands--With U.S. experience with tubeless percutaneous nephrolithotomy (PNL) now reaching 9 years, several studies have demonstrated the procedure's safety and effectiveness. Stone-free rates are similar to that seen with standard PNL using nephrostomy tubes, but postoperative hospitalization and narcotic use are decreased with the tubeless procedure, according to study results presented at the World Congress on Endourology here.
Amsterdam, Netherlands--A protective polyamide laser sheath for use during flexible ureteroscopy and laser lithotripsy showed little effect on deflection characteristics but markedly impaired irrigation flow in a new study from Canada.
Paris--External irradiation immediately following radical prostatectomy appears to improve biochemical progression-free survival and local control in prostate cancer patients at high risk of progression, according to results of a study from the European Organization for Research and Treatment of Cancer (EORTC).
Paris--Results of a second phase III trial suggest that a still-investigational immunotherapy agent offers a survival benefit in men with asymptomatic metastatic androgen-independent prostate cancer. Survival data from the more recent study support the findings of the first phase III trial of the agent, APC8015, also known as sipuleucel-T (Provenge), researchers reported at the European Cancer Conference here.
New York--Differential diagnosis of erectile dysfunction doesn't appear worth the effort when selecting a drug for treatment: No meaningful difference in the effect of the three available phosphodiesterase type-5 inhibitors was seen among men in a clinical trial, regardless of the cause of their ED, according to Hartmut Porst, MD.
Amsterdam, Netherlands--Researchers performing removal of challenging renal tumors using laparoscopic partial nephrectomy (LPN) in 300 consecutive cases have found that, compared with the first 100 cases, blood loss and overall complications decreased despite increased complexity of treating surgically difficult small renal tumors.
